Moleculin Biotech

MBRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.976 M

$0.41 +6.36%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$33.6M

Loss-making

Shares outstanding

5,336,350

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#443Aprea TherapeuticsAPRE$8.05M
#444Ensysce BiosciencesENSC$7.99M
#445Moleculin BiotechMBRX$7.98M
#446CNS PharmaceuticalsCNSP$7.86M
#447Bolt BiotherapeuticsBOLT$7.78M

Where these numbers come from

Share counts and financials for Moleculin Biotech are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.